In the present study, the sensitivity of detecting PC in early-stage patients was greatly improved from under 60% when using PhoSL-HP or CA19–9 alone to 85% when using both PhoSL-HP and CA19–9. The gene discussed is HP; the disease is pachyonychia congenita.